UK markets closed

Ipsen S.A. (IPSEF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
104.91-0.00 (-0.00%)
At close: 12:53PM EDT
Sign in to post a message.
  • y
    yiehom
    I like this sudden drop in a share price. It makes it a perfect value candidate on my watch list. Brilliant fundamentals: ROE, rev. growth and Cash Flows. What else?
  • K
    Kevin
    Need a current update. Stock has been under pressure for the past year due to generic concerns. Management has failed to allay fears.
  • C
    Country Squire
    Sales growth of 22.6% in 3rd qtr 2017! Find me another BioScience Pharmaceutical company producing at this level... any ??
  • A
    Aksel
    Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following discussions with the U.S. Food and Drug Administration (FDA), that a partial clinical hold effective immediately, for the pediatric population under the age of 14 was issued for studies conducted under IND120181... Great article here about IPSEY https://marketwirenews.com/news-releases/ipsen-initiates-partial-clinical-hold-for-palovarote-8394020785395819.html?i=c
    Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following discussions with the U.S. Food and Drug Administration (FDA), that a.
    Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced, following discussions with the U.S. Food and Drug Administration (FDA), that a.
    marketwirenews.com
  • K
    Kevin
    What is current outlook?
  • C
    Country Squire
    Onc Sales up higher than any other Oncology Company -globally! 19% - Average across Oncology peers is ~ 8-10% Sky is the limit in 2017-2018 for Ipsen in Oncology. See Excelis' recent hepatic and RCC trial success in partnership with Ipsen. Huge market opportunity
  • C
    Country Squire
    Yeah - this makes sense. Ipsen delivers some of the strongest financial growth in the industry... and the stock goes down -- Yep, makes perfect sense